DNA Diagnostics Market to Gain Momentum Through to 2022, Says KBV Research in Its Topical Study Available at MarketPublishers.com
06 Mar 2017 • by Natalie Aster
LONDON – The DNA diagnostics market gathered steam due to the factors like surging demand for efficient treatment for infectious and chronic illnesses, technological advances in diagnostic techniques, and increasing awareness about healthcare in the emerging countries.
The instruments segment takes lead in the worldwide DNA diagnostics product marketplace.
The rapid advancements in technology have resulted in the development of robust methodologies like microarrays, PCR, and gene sequencing, among others. These DNA-based methods of diagnosis enable to detect mutations, identify genes responsible for causing diseases, and diagnose myogenic disorders.
Bayer Corporation, Novartis International Ag, Sysmex Corporation, Roche Diagnostics, Hologic Corporation, Abbott Laboratories, Cepheid Inc, Thermo Fisher Scientific Inc., Illumina and Bio-Rad Laboratories are the top players in the market space.
Topical research report “Global DNA Diagnostics Market (2016-2022)” drawn up by KBV Research offers an exhaustive guide to the market, limelighting the uptake of DNA diagnostics worldwide. The market is categorised by product type, application, technology, and based on end user. A geographical market analysis is included, too. The study canvasses key factors influencing the market development, such as drivers, restraints and opportunities. The report sheds light on the degree of competition in the marketplace, contains detailed profiles of the 10 dominant players. Furthermore, the report provides detailed future outlook for the DNA diagnostics market and market size forecasts till 2022.
For other topical research reports by this publisher, follow KBV Research page at MarketPublishers.com.